Rarity PBC: Funding, Investors & Team (Sep 2026)
Rarity PBC is a biotechnology company that offers genetic treatments for immune diseases.
Rarity PBC has raised $4.6M across 1 funding round on record, the most recent a Seed of $4.6M announced in Oct 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rarity PBC Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Rarity PBC Funding Rounds
Rarity PBC Founders and Leadership Team
Contact details for the Rarity PBC team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Rarity PBC Funding Compared to Other Biotechnology Startups
Rarity PBC's latest round of $4.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rarity PBC in Biotechnology and Los Angeles
Companies Similar to Rarity PBC
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Rarity PBC Funding FAQs
What does Rarity PBC do?
Rarity PBC is a biotechnology company that offers genetic treatments for immune diseases.
How much funding has Rarity PBC raised?
Rarity PBC has raised $4.6M across 1 round on record. The most recent is a Seed of $4.6M announced in Oct 2025.
When did Rarity PBC last raise funding?
Rarity PBC's most recent funding round on record is a Seed of $4.6M, announced in Oct 2025.
Who is the CEO of Rarity PBC?
Paul Ayoub, PhD, MBA is listed as CEO at Rarity PBC.
Where is Rarity PBC headquartered?
Rarity PBC is based in Los Angeles, United States.
How many employees does Rarity PBC have?
Rarity PBC is in the 1-10 employee band.
How does Rarity PBC's funding compare to other Biotechnology startups?
Rarity PBC's latest round of $4.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Rarity PBC Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rarity PBC is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.